These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 14527910)
1. Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line. Brown T; Sigurdson E; Rogatko A; Broccoli D Ann Surg Oncol; 2003 Oct; 10(8):910-5. PubMed ID: 14527910 [TBL] [Abstract][Full Text] [Related]
2. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss. Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines. Murakami J; Nagai N; Shigemasa K; Ohama K Eur J Cancer; 1999 Jun; 35(6):1027-34. PubMed ID: 10533489 [TBL] [Abstract][Full Text] [Related]
4. Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment. Gomez DE; Tejera AM; Olivero OA Biochem Biophys Res Commun; 1998 May; 246(1):107-10. PubMed ID: 9600076 [TBL] [Abstract][Full Text] [Related]
5. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine. Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811 [TBL] [Abstract][Full Text] [Related]
6. Azidothymidine inhibition of thymidine kinase and synergistic cytotoxicity with methotrexate and 5-fluorouracil in rat hepatoma and human colon cancer cells. Weber G; Ichikawa S; Nagai M; Natsumeda Y Cancer Commun; 1990; 2(4):129-33. PubMed ID: 2369552 [TBL] [Abstract][Full Text] [Related]
7. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells. Zhen YS; Taniki T; Weber G Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584 [TBL] [Abstract][Full Text] [Related]
8. Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaks. Andreuccetti M; Allegrini G; Antonuzzo A; Malvaldi G; Conte PF; Danesi R; Del Tacca M; Falcone A Eur J Cancer; 1996 Jun; 32A(7):1219-26. PubMed ID: 8758257 [TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452 [TBL] [Abstract][Full Text] [Related]
10. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines. Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725 [TBL] [Abstract][Full Text] [Related]
11. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Strahl C; Blackburn EH Mol Cell Biol; 1996 Jan; 16(1):53-65. PubMed ID: 8524329 [TBL] [Abstract][Full Text] [Related]
13. Azidothymidine induces apoptosis and inhibits cell growth and telomerase activity of human parathyroid cancer cells in culture. Falchetti A; Franchi A; Bordi C; Mavilia C; Masi L; Cioppi F; Recenti R; Picariello L; Marini F; Del Monte F; Ghinoi V; Martineti V; Tanini A; Brandi ML J Bone Miner Res; 2005 Mar; 20(3):410-8. PubMed ID: 15746985 [TBL] [Abstract][Full Text] [Related]
14. Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer. Wang H; Zhou J; He Q; Dong Y; Liu Y Mol Med Rep; 2017 Jun; 15(6):4055-4060. PubMed ID: 28487971 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT). Periclou AP; Nandy P; Avramis VI In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870 [TBL] [Abstract][Full Text] [Related]
16. [The effect of telomerase inhibitors on oral squamous carcinoma cells]. Yang Z; Chen W; Zhang Q Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Jun; 21(3):231-4. PubMed ID: 12898773 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach. Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. Melana SM; Holland JF; Pogo BG Clin Cancer Res; 1998 Mar; 4(3):693-6. PubMed ID: 9533539 [TBL] [Abstract][Full Text] [Related]
19. [Azidothymidine inhibition of telomerase activity and proliferation of TJ905 human glioblastoma cells]. Liu J; Wang Q; Yu SZ; Zhao WJ; Sun CY; An TL; Wang LL; Chen XJ Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):183-8. PubMed ID: 19575855 [TBL] [Abstract][Full Text] [Related]
20. Telomere maintenance in telomerase-positive human ovarian SKOV-3 cells cannot be retarded by complete inhibition of telomerase. Gan Y; Mo Y; Johnston J; Lu J; Wientjes MG; Au JL FEBS Lett; 2002 Sep; 527(1-3):10-4. PubMed ID: 12220625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]